rs1017861 — CHD7 CHD7 AIS susceptibility locus

Intronic variant in CHD7, a chromatin remodeler critical for neural crest cell and skeletal development; the G allele is associated with susceptibility to adolescent idiopathic scoliosis and may influence neural crest-derived tissue patterning including thymus and inner ear morphogenesis

See your personal result for CHD7

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CHD7 rs1017861 — A Chromatin Remodeler's Footprint on Spinal Architecture and Immune Tissue Development

CHD711 CHD7
chromodomain helicase DNA binding protein 7, an ATP-dependent chromatin remodeler encoded at chromosome 8q12.2 is best known for its catastrophic role in CHARGE syndrome22 CHARGE syndrome
a rare developmental disorder causing Coloboma, Heart defects, Atresia choanae, Retarded growth, Genital abnormalities, and Ear anomalies — caused by heterozygous CHD7 loss-of-function mutations. Rare mutations eliminate CHD7 function; common intronic variants like rs1017861 operate more subtly — modulating how the gene is expressed during critical developmental windows.

CHD7 is an essential regulator of neural crest cells33 neural crest cells
a migratory embryonic cell population that gives rise to the peripheral nervous system, craniofacial skeleton, cardiac outflow tract, thymus, parathyroid glands, and inner ear. The thymus — and therefore much of the adaptive immune system's T-cell repertoire — develops from neural crest-derived pharyngeal pouch tissue under CHD7 control. This dual role in skeletal patterning and immune-system organogenesis places CHD7 in the innate and developmental immunity category alongside other genes whose structural contributions to the immune system matter as much as their direct immunological signalling.

The Mechanism

Rs1017861 lies in intron 2 of CHD7 (NM_017780.4:c.-175+27072A>G, GRCh38 chr8:60,706,154). The intronic location suggests it acts as a regulatory variant — influencing CHD7 expression levels or splice-site usage in specific tissues during development — rather than altering the CHD7 protein sequence. Precise cis-eQTL data for rs1017861 have not been published, but the variant's location near exons 2-4, where disease-associated haplotypes cluster most strongly, places it within the same regulatory neighbourhood as the functional polymorphisms identified in the Gao 2007 fine-mapping study.

CHD7 remodels chromatin at enhancers active during paraxial mesoderm and neural crest differentiation. When CHD7 activity is perturbed — even subtly — the transcriptional programmes that pattern the axial skeleton, paraspinal musculature, inner ear, and thymus are altered. The result in common-variant carriers is not a structural birth defect but a quantitative shift in tissue patterning that, at the population level, predisposes to adolescent idiopathic scoliosis (AIS) and possibly to subtle immune-tissue variation.

The Evidence

The primary genetic association comes from Gao et al. 200744 Gao et al. 2007
CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis — Am J Hum Genet, a linkage and association study of 52 IS families that produced a multipoint LOD of 2.77 (p = 0.0028) for chromosome 8q12, with fine-mapping of 23 CHD7 SNPs identifying significant disease-associated haplotypes (p < 1×10⁻⁴) over exons 2-4. This was the first report naming CHD7 as an IS susceptibility gene.

Direct evidence for rs1017861 itself comes from Borysiak et al. 202055 Borysiak et al. 2020
CHD7 gene polymorphisms in female patients with idiopathic scoliosis — BMC Musculoskelet Disord, a Polish case-control study of 211 female AIS patients and 83 controls. The rs1017861 polymorphism showed statistically significant association with IS susceptibility (p < 0.01) and with curve severity and progression rate (p < 0.05). The authors conclude that CHD7 should be considered an IS-modifying factor.

Replication has been mixed. Tilley et al. 201366 Tilley et al. 2013 failed to replicate CHD7 association across 22 SNPs in 244 European-descent familial IS families (p > 0.01), highlighting that familial and sporadic IS may have different genetic architectures, and that replication across ethnicities and study designs is incomplete. A 2025 study (Dai et al., PMID 39206768) further found that rs1017861 does not significantly predict brace treatment outcome, suggesting the variant is relevant for susceptibility rather than disease course once AIS is established.

The evidence level for this variant is therefore moderate — statistically significant association in at least one case-control study with plausible biological mechanism, but inconsistent replication and absent population-level GWAS confirmation at genome-wide significance thresholds.

Practical Actions

The primary actionable consequence is heightened awareness of scoliosis risk during adolescent growth. AIS emerges during the pubertal growth spurt (ages 10-16), has a strong female predominance, and responds well to bracing when detected at curves of 20-40°. GG carriers, particularly adolescent girls, benefit most from systematic spinal assessment during this window.

CHD7's role in neural crest-derived immune tissue development — especially thymus organogenesis — also connects this variant to the innate-infection category. Carriers with a history of recurrent infections, unusual immune responses, or sensorineural hearing loss may have a developmental basis worth investigating, though direct immunological evidence for rs1017861 specifically is not yet published.

Interactions

CHD7 at 8q12 sits alongside other AIS susceptibility loci identified in recent GWAS. The most studied co-loci include rs1978060 (TBX1, 22q11.21) and rs10738445 (BNC2). Combined burden across multiple AIS susceptibility variants predicts risk better than any single locus, though specific compound action data for the CHD7 + TBX1 or CHD7 + BNC2 combinations are not yet published. The developmental overlap between CHD7 and TBX1 — both are essential regulators of pharyngeal arch derivatives including the thymus, inner ear, and paraspinal tissues — makes a compound interaction biologically plausible.

Genotype Interpretations

What each possible genotype means for this variant.

AA Lower-Risk Genotype Normal

Reference allele homozygote — lower genetic susceptibility to adolescent idiopathic scoliosis at this CHD7 locus

You carry two copies of the A reference allele at rs1017861 in CHD7. This genotype is associated with lower susceptibility to adolescent idiopathic scoliosis at this locus compared with G-allele carriers. About 23% of people globally share this genotype, though it is considerably more common in African populations (~75%) and less common in East Asian populations (~7%). Your CHD7-related skeletal and immune-tissue developmental risk at this locus is at the lower end of the population spectrum.

AG One Risk Allele Intermediate

One G allele modestly increases CHD7-related susceptibility to adolescent idiopathic scoliosis

You carry one copy of the G allele at rs1017861. The G allele has been associated with increased susceptibility to adolescent idiopathic scoliosis (AIS) in case-control studies of European populations, with statistical association reaching p < 0.01 in the Borysiak 2020 study. About 50% of people globally are heterozygous at this position. The per-allele effect is modest — this variant is one of multiple genetic contributors to AIS risk — but the additive model means one G copy confers intermediate susceptibility. For adolescents (especially girls) with this genotype, awareness of spinal posture during the pubertal growth spurt is the most actionable implication.

GG Two Risk Alleles High Risk

Two G alleles confer the highest CHD7-locus susceptibility for adolescent idiopathic scoliosis and potential neural crest-derived tissue variation

CHD7 is required for the correct differentiation of neural crest cells that populate the pharyngeal arches, giving rise to the thymus (and thus the T-cell immune repertoire), parathyroid glands, cardiac outflow tract, craniofacial skeleton, and inner ear sensory epithelium. Rare CHD7 mutations eliminate these programmes entirely, causing CHARGE syndrome. Common G-allele variants like rs1017861 are proposed to reduce CHD7 expression or alter its splicing in tissue-specific ways, producing quantitative shifts in these developmental programmes rather than structural birth defects.

For scoliosis: the G-allele association with curve severity and progression (p < 0.05, Borysiak 2020) adds a disease-course dimension beyond simple susceptibility. While the 2025 Dai et al. study found no significant brace-outcome prediction for rs1017861, it tested a specific Chinese cohort and a specific treatment endpoint — the Borysiak data on curve severity in European patients remains the most direct evidence for a GG dose-response.

Population note: the G allele is the major allele in East Asian and South Asian populations (gnomAD G freq ~0.74 and ~0.72 respectively), meaning GG homozygosity is common in these groups and the ancestral comparison context differs substantially from European studies. Replication in East Asian cohorts — where GG is the modal genotype — is important context for personalizing risk estimates.